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The Cholera and Other Vibrio Illness Surveillance (COVIS) system is a national surveillance system for human 
infection with pathogenic species of the family Vibrionaceae, which cause vibriosis. The Centers for Disease 
Control and Prevention (CDC) maintains COVIS. Information from COVIS helps track Vibrio infections and 
determine host, food, and environmental risk factors for these infections.
CDC initiated COVIS in collaboration with the Food and Drug Administration and the Gulf Coast states (Alabama, 
Florida, Louisiana, Mississippi, and Texas) in 1988. Using the COVIS report form (available at http://www.cdc.
gov/nationalsurveillance/PDFs/CDC5279_COVISvibriosis.pdf ), participating health officials report cases of 
vibriosis and cholera. The case report includes clinical data, including information about underlying illness; 
detailed history of seafood consumption; detailed history of exposure to bodies of water, raw or live seafood or 
their drippings, or contact with marine life in the seven days before illness onset; and traceback information on 
implicated seafood. 
Before 2007, only cholera, which by definition is caused by infection with toxigenic Vibrio cholerae serogroup 
O1 or O139, was nationally notifiable. In January 2007, infection with other serogroups of V. cholerae and other 
species from the family Vibrionaceae also became nationally notifiable, as vibriosis. 
CDC requests that all State Health Departments send all Vibrio isolates to CDC for additional characterization. For 
example, CDC serotypes all V. parahaemolyticus isolates received. For V. cholerae, CDC identifies serogroups O1, 
O75, O139, and O141 and determines whether the isolate produces cholera toxin. Although all Vibrio infections 
are nationally notifiable, many cases are likely not recognized because Vibrios are not easily identified on routine 
enteric media. A selective medium, such as thiosulfate citrate bile salts sucrose agar (TCBS) should be used.
This report summarizes human Vibrio infections occurring during 2010 reported to COVIS. 
Results are presented in two categories: (1) infection with pathogenic species of the family 
Vibrionaceae (other than toxigenic Vibrio cholerae serogroups O1 and O139), 
which cause vibriosis; this category includes infection with toxigenic V. 
cholerae of serogroups other than O1 and O139, and (2) infection with 
toxigenic V. cholerae serogroups O1 and O139, which cause cholera. 
While many Vibrio species are well-recognized human pathogens, 
the status of some species (including Photobacterium damselae 
subsp. damselae (formerly V. damsela), V. furnissii, V. metschnikovii, 
and V. cincinnatiensis) as human enteric or wound pathogens is 
less clear. 
Understanding the routes by which infection is transmitted is 
essential for control. For vibriosis, cases are summarized by place 
of exposure (travel-associated vs. domestically acquired). For 
domestically acquired vibriosis, transmission routes (e.g., foodborne, 
non-foodborne, and unknown, see Appendix for classification 
method) are determined based on reported patient exposures and 
specimen sites. For toxigenic V. cholerae (all serogroups), exposures are 
summarized by place of exposure (travel-associated vs. domestically  
acquired) and then, if information is available, by source (such as 
consumption of contaminated seafood).
This Gram-stain depicts flagellated Vibrio 
comma bacteria, a strain of V. cholerae.
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I. Vibriosis 
Pathogenic species of the family Vibrionaceae (excluding toxigenic V. cholerae O1 and O139)
In 2010, 927 Vibrio infections (excluding toxigenic V. cholerae O1 and O139) were reported to COVIS (Table 1). 
Among patients for whom information was available, 272 (33%) of 838 were hospitalized, and 45 (6%) of 784 
died. The most frequently reported species was V. parahaemolyticus, which was isolated from 421 (45%) of the 
927 patients. Of the patients infected with V. parahaemolyticus for whom information was available, 84 (22%) of 
383 were hospitalized, and 2 of 366 (1%) died. V. alginolyticus was isolated from 152 (16%) of the 927 patients;  
of the patients for whom information was available, 18 (14%) of 127 were hospitalized, and 1 (1%) of 114 died.  
V. vulnificus was isolated from 133 (14%) of the 927 patients; of the patients for whom information was available, 
93 (75%) of 124 were hospitalized, and 36 (31%) of 116 died. 
Table 1. Vibriosis cases by species, selected demographic characteristics, and outcome, United States, 2010
Demographic Characteristics Outcomes
Vibrio Species Cases Age (years) Sex Hospitalizations Deaths
N % Median Range Male (n/N) % n/N % n/N %
V. alginolyticus 152 16 35.5 2–84 88/149 59 18/127 14 1/114 1
V. cholerae (excluding 
toxigenic V. cholerae O1 
and O139)*




3 0 56 15–66 2/3 67 2/4 50 0/3 0
V. fluvialis 50 5 63 2–87 37/50 74 17/47 39 2/44 5
Grimontia hollisae  
(formerly V. hollisae) 15 2 52 33–93 8/15 53 9/15 60 0/11 0
V. metschnikovii 2 0 32 32 1/1 100 1/2 50 0/2 0
V. mimicus† 15 1 48 2–67 7/15 47 5/15 27 0/14 0
V. parahaemolyticus 421 45 47.5 1–90 257/414 62 84/383 22 2/366 1
V. vulnificus 133 14 57 2–87 112/132 85 93/124 75 36/116 31
Species not identified 56 6 55 2–88 30/53 57 15/47 32 1/41 2
Multiple species§ 11 1 49 13–65 8/11 73 5/11 45 0/10 0
Total 927 100 49 1–96 597/910 66 272/838 32 45/784 6
*Includes 62 non-toxigenic V. cholerae (non-O1 non-O139 [57 cases], O1 [2 cases], O139 [1 case], non-O1 (2 cases) (ie, patient tested negative for serogroup O1 
and was not tested for other serogroups)and 7 toxigenic V. cholerae (O75 [6 cases], O141 [1 case]).
†Three patients had toxigenic V. mimicus infection.
§ The following combinations of Vibrio species were isolated from patients infected with multiple species : V. parahaemolyticus, V. vulnificus (5 patients);  
V. fluvialis, V. parahaemolyticus (4 patients); toxigenic V. cholerae O75, V. mimicus (1 patient); V. alginolyticus, V. harveyi (1 patient). None of these are included  
in the rows for individual species. 
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Geographic Location
Of the 927 cases of vibriosis, 265 (29%) were reported from Gulf Coast states, 216 (23%) from Pacific Coast states, 
316 (34%) from Atlantic Coast states, and 130 (14%) from non-coastal states (Figure 1). 
The Vibrio species reported most frequently from Gulf Coast states were V. vulnificus (29%), V. parahaemolyticus 
(25%), V. alginolyticus (22%), and V. cholerae (excluding toxigenic V. cholerae O1 and O139) (8%). The Vibrio species 
reported most frequently from non-Gulf Coast states were V. parahaemolyticus (54%), V. alginolyticus (14%), V. 
vulnificus (9%), V. cholerae (excluding toxigenic V. cholerae O1 and O139) (7%), and V. fluvialis (6%).
Figure 1. Number of cases of Vibrio infections (excluding toxigenic V. cholerae O1 and O139), by state,  
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Transmission categories and reported exposures
Among the 927 vibriosis patients, 56 (6%) reported international travel in the 7 days before illness began. Among 
the 871 domestically-acquired vibriosis cases, 459 (53%) were classified as confirmed or probable foodborne, 307 
(35%) as confirmed or probable non-foodborne, and 105 (12%) as having unknown transmission route (Figure 2). 
Illness reports peaked in the summer months for all categories, but the peak was most pronounced for foodborne 
infections (Figure 3). 
Among the 182 patients with foodborne vibriosis who reported eating a single seafood item (Table 2), 114 (63%) 
ate oysters (90% of whom consumed them raw), 13 (7%) ate clams (85% of whom consumed them raw), 14 (8%) 
ate shrimp, and 18 (10%) ate finfish. 
For cases with non-foodborne transmission, 222 (72%) patients reported having skin exposure to a body of water 
within 7 days before illness began, 50 (16%) reported handling seafood, and 49 (16%) reported contact with 
marine wildlife. 
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Figure 3. Domestically-acquired vibriosis cases, by month of illness onset or specimen collection  
(when onset date not available) and transmission route, 2010 (N=871).
Month of illness onset















Total confirmed and 
probable foodborne
Total confirmed and 
probable non-foodborne
Unknown
Table 2. Seafood exposures among 182 patients with domestically-acquired foodborne vibriosis who reported 
eating a single seafood item in the week before illness onset, 2010.
Mollusks Crustaceans Other
Oysters Clams Mussels Shrimp Lobster Crab Crayfish Other Shellfish* Finfish
†
Patients who ate 
single seafood item  
n (% of 182)
114 (61) 13 (7) 1 (0.5) 14 (8) 1 (0.5) 15 (8) 4 (2) 2 (1) 18 (10)
Patients who ate  
the single seafood 
item raw, n (% of n  
in row above)
103 (90) 11 (85) 0 (0) 3 (21) 0 (0) 2 (13) 0 (0) 2 (100) 6 (33)
* Other shellfish reported: periwinkles, limpets
† Finfish reported: ak kalulu, catfish, codfish, grouper, kingfish, salmon, swordfish, tuna, white fish
Laboratory 
In 2010, 188 isolates were confirmed at CDC as V. parahaemolyticus; 28 serotypes of V. parahaemolyticus were 
identified: 26% were O4:Kuk, 15% were O1:Kuk, and 10% were O3:Kuk, 2% were of the pandemic clone serotype 
O3:K6, and 48% were one of 24 other serotypes. 
Page 6 of 9August 2013
Toxigenic V. cholerae, excluding serogroups O1 and O139
Serogroup O141 
In 2010, one patient with toxigenic V. cholerae serogroup O141 infection was reported. This patient reported 
consumption of raw oysters. The patient was not hospitalized. 
Serogroup O75
In 2010, six patients with toxigenic V. cholerae serogroup O75 infection were reported. All infections were acquired 
domestically, and all patients reported consumption of seafood (four ate raw oysters, one ate cooked oysters, and 
one ate baked mussels, boiled crab, boiled shrimp, and sushi rolls). Two patients were hospitalized, and none died. 
Additionally, one case with onset in 2009 was laboratory confirmed and reported in 2010. This patient reported 
consumption of broiled shrimp, crab, and scallops and was hospitalized. 
Table 3. Cases of toxigenic V. cholerae O141 and O75 infections, 2010. 
State Age Sex Month of Illness onset
International 
Travel Exposure Serogroup
Connecticut 53 M August No Consumption of raw oysters O141
Ohio 37 M May No Consumption of raw oysters O75
Pennsylvania 53 F June No Consumption of raw oysters O75
Georgia 39 F October No Consumption of raw oysters O75
Louisiana 52 M October* No
Consumption of baked mussels, 
boiled crab, boiled shrimp, and 
sushi rolls
O75
Florida 12 M October No Consumption of raw oysters O75
Kentucky 67 M Unknown No Consumption of cooked oysters O75
Pennsylania 36 F October† No Consumption of broiled shrimp, crab, and scallops O75
*This patient also was infected with V. mimicus
†Illness occurred in 2009, but isolate was submitted to CDC in October 2010
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II. Cholera 
Serogroup O1 & O139
In 2010, 15 patients with toxigenic V. cholerae serogroup O1 infection were reported; 14 infections were culture-
confirmed, and one was confirmed by serologic testing. Of the 15 patients, seven were hospitalized; four reported 
seeking care at an emergency department. None died. All cases were associated with international travel; of 
particular note, eight patients reported travel to Haiti, where a cholera outbreak began on October 21, 2010. No 
cases of V. cholerae O139 were reported. 
Table 4. Cases of toxigenic V. cholerae O1 infection, 2010 
State Age Sex Month of Illness Onset
International 
Travel Exposure Serogroup
New York 44 M March Yes Pakistan O1 ET Ogawa
Texas 54 F March Yes Resident of India O1 ET Ogawa
Ohio 3 M July Yes Indonesia O1 ET Ogawa
Ohio 41 M July Yes Indonesia O1 ET Ogawa
Ohio 8 F July Yes Indonesia O1 ET Ogawa
Georgia 20 F October Yes Resident of Pakistan O1 ET Ogawa
Florida 84 F October Yes Haiti O1 ET Ogawa
Florida 9 F November Yes Haiti O1 ET Ogawa
Virginia 61 M November Yes Haiti O1 ET Ogawa
Florida 28 F November Yes Haiti O1 ET Ogawa
Florida 40 F November Yes Haiti O1 ET Ogawa
North Carolina 59 M December Yes Haiti SEROPOSITIVE
Florida 71 F December Yes Haiti O1 ET Ogawa
Florida 39 M December Yes Haiti O1 ET Ogawa
Texas 2 M December Yes Pakistan O1 ET Ogawa
III. Recent publications using COVIS data
Iwamoto M, Ayers T, Mahon BE, Swerdlow DL. Epidemiology of Seafood-Associated Infections in the United States. 
Clin Micro Rev. 2010: 23: 399-411. 
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Appendix
Method for Classification of Transmission Routes in the Cholera and Other Vibrio Illness 
Surveillance (COVIS) System
I. Exposure categories
To classify transmission routes, the first step is to categorize patient exposures. For a given illness episode, 
>1 patient exposure can be reported to COVIS; each reported exposure is categorized individually. If all 
exposures fall into a single category, then the report is considered to have a single exposure category. If not, 
the report is considered to have multiple exposure categories. For a given case, if any exposure is reported, 
we assume that other exposures for which information was not reported were not present. Exposures are 
classified using three categories:
1.  Seafood consumption: Ingestion of seafood. Does not include touching seafood.
2.  Marine/estuarine contact: Includes direct skin contact with marine/estuarine life, bodies of water,  
     or drippings from raw or live seafood. 
3.  Unknown exposure: no exposure history reported.
II. Specimen site categories
The next step in classifying transmission routes is to categorize reported specimen sites. For a given illness 
episode, >1 specimen site can be reported; each reported site is categorized individually. If all specimen 
sites fall into a single category, then the report is considered to have a single specimen site category. If not, 
then the report is considered to have multiple specimen site categories. Specimen sites are classified using 
five categories:
1.  Gastrointestinal site (GI): stool, bile, appendix, rectum, gall bladder, colon 
2.  Blood or other normally sterile site (sterile): blood, CSF, peritoneal fluid, lumbar disc fluid,  
     lymph node, bullae
3.  Skin or soft tissue site (SST): wound, any ear (other than otitis media and middle ear, which are  
     included in ‘other, non-sterile site’), appendage, tissue
4.  Other, non-sterile site (ONS): urine, sputum, aspirate, bronchial washing, effusion, catheter,  
     endotracheal, eye, nasal, placenta, respiratory, sinus, tonsil
5.  Unknown site (unknown): no specimen site reported or no site specified for ‘other’
Note: The lists of sites for each category above are not intended to be exhaustive. Rather, they reflect the 
sites actually reported to COVIS and can be updated, if new sites are reported.
III. Transmission route
The final step in classifying transmission involves review of exposure and specimen site categories for each 
reported case. Reports are classified into one of three transmission routes, foodborne, non-foodborne, and 
unknown, based on criteria below:
1.  Single exposure category: seafood consumption
•	 Confirmed Foodborne: Vibrio isolated only from GI or sterile site OR Vibrio isolated from multiple 
specimen site categories, with GI reported. 
•	 Probable Foodborne: Vibrio isolated only from SST, ONS, or unknown sites OR Vibrio isolated from 
multiple specimen site categories, not including GI.
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2.  Single exposure category: marine/estuarine contact 
•	 Confirmed Non-foodborne: Vibrio isolated only from SST or sterile site OR Vibrio isolated from multiple 
specimen site categories, with SST reported.
•	 Probable Non-foodborne: Vibrio isolated only from GI, ONS, or unknown sites OR Vibrio isolated from 
multiple specimen site categories, not including SST.
3.  Multiple exposure categories: both seafood consumption AND marine/estuarine contact 
•	 Confirmed Foodborne: Vibrio isolated only from a GI site OR Vibrio isolated from multiple specimen site 
categories, with GI reported and SST not reported.
•	 Confirmed Non-foodborne: Vibrio isolated only from a SST site OR Vibrio isolated from multiple 
specimen site categories, with SST reported and GI not reported.
•	 Unknown: Vibrio isolated only from a sterile, ONS, or unknown site OR Vibrio isolated from multiple 
specimen site categories, including either 1) both GI and SST or 2) neither GI nor SST.
4.  Unknown or no reported exposure (note that categorization is the same as for  
      multiple exposure categories) 
•	 Confirmed Foodborne: Vibrio isolated only from a GI site OR Vibrio isolated from multiple specimen site 
categories, with GI reported and SST not reported.
•	 Confirmed Non-foodborne: Vibrio isolated only from a SST site OR Vibrio isolated from multiple 
specimen site categories, with SST reported and GI not reported.
•	 Unknown: Vibrio isolated only from a sterile, ONS, or unknown site OR Vibrio isolated from multiple 
specimen site categories, including either 1) both GI and SST or 2) neither GI nor SST. 
NCEZID Atlanta: 
For more information please contact Centers for Disease Control and Prevention 
1600 Clifton Road NE, Atlanta, GA 30333 MS C-09 
Telephone: 1-404-639-2206  
Email: cdcinfo@cdc.gov
